Business Description
Artelo Biosciences is a US-based clinical-stage drug development company focused on treatments that work through the body's lipid-signaling systems. Its pipeline includes three candidates targeting conditions such as cancer-related appetite loss, nerve pain, anxiety, depression, PTSD, and epilepsy. Founded in 2011 and headquartered in Solana Beach, California, the company operates under a name it adopted in 2017.
